Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Mithra Pharmaceuticals S.A.
  6. Summary
    MITRA   BE0974283153

MITHRA PHARMACEUTICALS S.A.

(MITRA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
07/29/2021 07/30/2021 08/02/2021 08/03/2021 08/04/2021 Date
20.15(c) 20.35(c) 20.15(c) 19.66(c) 19.4(c) Last
41 924 26 844 42 863 35 917 57 016 Volume
-4.05% +0.99% -0.98% -2.43% -1.32% Change
More quotes
Estimated financial data (e)
Sales 2021 71,8 M 85,0 M 85,0 M
Net income 2021 -32,2 M -38,1 M -38,1 M
Net Debt 2021 48,7 M 57,6 M 57,6 M
P/E ratio 2021 -41,2x
Yield 2021 -
Sales 2022 266 M 315 M 315 M
Net income 2022 144 M 171 M 171 M
Net cash position 2022 36,6 M 43,3 M 43,3 M
P/E ratio 2022 3,98x
Yield 2022 -
Capitalization 848 M 1 004 M 1 004 M
EV / Sales 2021 12,5x
EV / Sales 2022 3,05x
Nbr of Employees 229
Free-Float 59,5%
More Financials
Company
Mithra Pharmaceuticals SA is a Belgian-based company active in the pharmaceutical industry. The Company is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The Company provides three development... 
Sector
Pharmaceuticals
Calendar
09/24Earnings Release
More about the company
Ratings of Mithra Pharmaceuticals S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about MITHRA PHARMACEUTICALS S.A.
07/15MITHRA PHARMACEUTICALS S A : ExeVir and Mithra announce manufacturing collaborat..
PU
07/15Exevir and Mithra Announce Manufacturing Collaboration for Innovative Covid-1..
CI
07/05MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement ..
AQ
07/02MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement ..
PU
06/25MITHRA PHARMACEUTICALS S A : successfully renegotiates the earnouts relating to ..
AQ
06/24MITHRA PHARMACEUTICALS S A : successfully renegotiates the earnouts relating to ..
PU
06/22Estelle Oral Contraceptive Now Available In the United States
AQ
06/21MITHRA PHARMACEUTICALS : Estelle® Oral Contraceptive Now Available In The United..
PU
05/28Mayne - Nextstellis Receives FDA Marketing Exclusivity And Phase III Data Pub..
AQ
05/27MAYNE PHARMA : Nextstellis receives fda marketing exclusivity and phase iii data..
AQ
05/27MITHRA PHARMACEUTICALS S A : Nextstellis® Receives FDA Marketing Exclusivity and..
PU
05/21Today on Wall Street: Poor manufacturing data boosts indexes
05/21MITHRA PHARMACEUTICALS S A : Announces European Approval of Estelle
AQ
05/20MITHRA PHARMACEUTICALS S A : Announces European Approval of Estelle®
PU
05/20MITHRA PHARMACEUTICALS S.A. : Proxy Statments
CO
More news
News in other languages on MITHRA PHARMACEUTICALS S.A.
07/15Galapagos onderuit op rode beurs
07/15Brussel opnieuw in het rood
07/15BRUSSELS STOCK EXCHANGE : Lagere opening Bel20 voorzien
07/15Mithra werkt samen met ExeVir voor covidtherapie
07/15MITHRA PHARMACEUTICALS S A : ExeVir et Mithra annoncent leur collaboration pour ..
More news
Chart MITHRA PHARMACEUTICALS S.A.
Duration : Period :
Mithra Pharmaceuticals S.A. Technical Analysis Chart | MITRA | BE0974283153 | MarketScreener
Technical analysis trends MITHRA PHARMACEUTICALS S.A.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 19,40 €
Average target price 35,48 €
Spread / Average Target 82,9%
EPS Revisions
Managers and Directors
Leon Van Rompay Chief Executive Officer
Christophe Maréchal Chief Financial Officer
Patricia van Dijck Chairman
Patrick Kellens Chief Information Officer
Graham K. Dixon CSO, Head-Research & Development
Sector and Competitors